Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
6
100%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
6(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 36 (100.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Bypass Angioplasty Revascularization Investigation (BARI)

NCT00000462
completedphase_3

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

NCT00000478
completedphase_3

Thrombolysis in Myocardial Infarction (TIMI)

NCT00000505
completedphase_3

Emory Angioplasty Versus Surgery Trial (EAST)

NCT00000465
completedphase_3

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

NCT00000552
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00000462Phase 3

Bypass Angioplasty Revascularization Investigation (BARI)

Completed
NCT00000478Phase 3

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Completed
NCT00000505Phase 3

Thrombolysis in Myocardial Infarction (TIMI)

Completed
NCT00000465Phase 3

Emory Angioplasty Versus Surgery Trial (EAST)

Completed
NCT00000552Phase 3

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Completed
NCT00000510Phase 3

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6